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Abstract
Background: Randomised controlled trials (RCTs) are considered the gold standard when evaluating the causal
effects of healthcare interventions. When RCTs cannot be used (e.g. ethically difficult), the interrupted time series
(ITS) design is a possible alternative. ITS is one of the strongest quasi-experimental designs. The aim of this
methodological study was to describe how ITS designs were being used, the design characteristics, and reporting
in the healthcare setting.
Methods: We searched MEDLINE for reports of ITS designs published in 2015 which had a minimum of two data
points collected pre-intervention and one post-intervention. There was no restriction on participants, language of
study, or type of outcome. Data were summarised using appropriate summary statistics.
Results: One hundred and sixteen studies were included in the study. Interventions evaluated were mainly
programs 41 (35%) and policies 32 (28%). Data were usually collected at monthly intervals, 74 (64%). Of the 115
studies that reported an analysis, the most common method was segmented regression (78%), 55% considered
autocorrelation, and only seven reported a sample size calculation. Estimation of intervention effects were reported
as change in slope (84%) and change in level (70%) and 21% reported long-term change in levels.
Conclusions: This methodological study identified problems in the reporting of design features and results of ITS
studies, and highlights the need for future work in the development of formal reporting guidelines and
methodological work.
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Background
Rigorous evaluations are the cornerstone of evidence-
based healthcare. The gold standard for evaluating the
causal effect of an intervention is a randomised con-
trolled trial (RCT). However, RCTs do have limitations,
they can be costly, unethical or impractical to conduct
[1–3]. Therefore, researchers must consider alternative
designs to evaluate interventions and quasi-experimental
studies are one possible solution [4]. Quasi-experimental
studies do not use randomisation and may use both pre-
and post-intervention data. Interrupted time series (ITS)
is considered one of the strongest quasi-experimental
designs [4].
In an ITS design, data are collected at multiple and
equally spaced time points (e.g. weekly, monthly, or
yearly) before and after an intervention. Knowing the
exact time when an intervention occurs is an important
feature. The main objective of an ITS is to examine
whether the data pattern observed post-intervention is
different to that observed pre-intervention. There are a
range of effect estimates to describe the impact of the
intervention. For example, a change in level corresponds
to the difference in the time point of interest to the pre-
dicted pre-intervention trend or a change in slope which
is the difference between the post-and pre-intervention
slopes [5].
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When designing an ITS design and analysing the data
there are important characteristics that need to be con-
sidered, these include (1) autocorrelation, whereby data
collected closely together are correlated with each other,
(2) nonstationary or secular trend, which is where the
data are increasing or decreasing over time irrespective
of any intervention, (3) seasonality or cyclic patterns, (4)
outliers, (5) other interventions (interruptions) occurring
in the data series, and (6) sample size.
Three systematic reviews [5–7] have looked at ITS de-
signs but all focussed on specific, narrow areas. Polus et
al [6] focused on pre-specified intervention types (for ex-
ample behavioural/educational, clinical, environmental,
health policy, and health systems) and only included 16
studies from Cochrane Effective Practice and Organisa-
tion of Care (EPOC) reviews. The key findings were ITS
terminology is used for a variety of study designs and
when an ITS design is used the intervention is at the or-
ganisational level. Jandoc et al [7] included 220 studies
but only focused on drug utilisation. They found ITS de-
signs increasingly being used but reporting standards
varied. Ramsay et al [5] concentrated on mass media in-
terventions, included 58 studies, concentrated on meth-
odology quality and concluded that in most cases there
was poor reporting of study design. To our knowledge,
no study has assessed the breadth of use of ITS designs
across healthcare settings.
The aim of this methodological study was to identify a
cohort of ITS designs across all healthcare settings and
to describe how ITS are being used, what design charac-
teristics are considered, and how they are reported.
Methods
This methodological study was conducted according to a
prespecified study protocol [8].
Inclusion and exclusion criteria
We included ITS with a minimum of two data points
pre and one post-intervention that assessed a health or
healthcare intervention (e.g. programs, policies, or edu-
cational interventions). Systematic reviews, meta-
analysis, RCTs, ITS designs with a control group or
studies that did not use an ITS analysis were excluded.
There were no restrictions on participants, language of
study, or the type of outcome.
Search strategy
We searched MEDLINE(R) and Epub Ahead of Print,
In-Process & Other Non-Indexed Citations and Daily) in
October 2016 for ITS designs published in 2015. The
search strategy is in Additional file 1.
JH screened titles and abstracts identified by the
search for inclusion. CR and SF double assessed 10% of
the titles and abstracts and if there were no
disagreements then JH would proceed to single screen-
ing. Full-text copies for all the potential studies were ob-
tained and assessed for inclusion by JH with CR and SF
double assessing 10%.
Data extraction and analysis
A data extraction form was developed and piloted on
three randomly selected papers by all authors. JH re-
corded the relevant details of all included studies onto a
data extraction form. Two authors (CR and SF) inde-
pendently assessed 10% of randomly selected studies and
if there were no disagreements then JH would proceed
to data extract the remaining studies. Data extracted
from the studies consisted of: definition of study design
(e.g. ITS, before-and-after), country of study, study ob-
jectives (population, intervention and the outcomes of
interest), type and level of intervention, participants,
data source, type of outcome, the number of data points
collected pre-and post-intervention and the frequency,
study methodology characteristics, estimations of inter-
vention effects and the reporting details of the abstract
and discussion. We based data extraction on the primary
outcome and if no defined primary outcome was re-
ported, we used the first reported outcome. We sum-
marised data using descriptive statistics (numbers and
percentages or median, 25th, and 75th centile).
As a methodological study, risk of bias assessment was
not performed on individual studies.
Results
The search strategy identified 3111 title and abstracts
(Fig. 1). After removing duplicates (187) and excluding
2552 titles and abstracts that did not meet the inclusion
criteria, 372 full-text studies were assessed for eligibility.
Of these, 256 articles were excluded with the majority
(170) having too few time points. A total of 116 articles
were included in the study and the list of included stud-
ies is provided in Additional file 2. As there were no dis-
agreements in the screening and data extraction, CR and
SF only double assessed 10%.
In the abstract of the included studies, the intervention
was clearly defined in 110 (95%) of studies (Table 1). The
method of analysis was reported in 57% of the studies and
the number of pre-and post-intervention data points were
stated in 29% and 28% of studies respectively. The main
results were reported in three quarters of the studies.
Characteristics of the included studies are presented in
Table 2. Seventy four (64%) studies provided a study defin-
ition in at least the title, abstract, or the main paper. Of
these 9 (12%) provided a definition in the title, abstract,
and main paper with only two consistently giving the
same definition. Examples of study definitions used in-
clude ITS, quasi-experimental, time series, observational,
cohort, and cross-sectional study. The majority of studies
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were from the US (34%), the UK (16%), Asia (16%), and
Europe (12%). The type of intervention varied, the most
common being programs (35%) and policies (28%). Inter-
ventions were mainly at the hospital level (63%), aimed at
health professionals (79%), and over half of the data came
from hospitals (55%). Data were mainly collected at
monthly intervals (64%), and the number of data points
collected pre-and post-intervention was mostly the same
within any given study with a median ratio of one (25th,
75th centile 1–2). Additionally, Study objectives were
clearly defined in 85 (73%) of studies and 17 (15%) gave a
rationale for using an ITS design. The majority of the
studies investigated one intervention (78%), 15% studied
two and 8% studied three or more. Only 30 (26%) speci-
fied a primary and/or secondary outcome and 107 (92%)
clearly defined when the intervention occurred. Eighty-
three (72%) gave a funding source statement, 7 (6%) stud-
ies referred to a study protocol, and only one study was
non-English (Spanish).
Characteristics of the methodology used in each study
showed all but one study provided a description of the
analysis, with segmented regression analysis being used
in 90 (78%) studies (Table 3). Autocorrelation was con-
sidered in 63 (55%) studies, of these only 40 (63%) re-
ported any formal testing. Only 9 (8%) studies
considered nonstationary and seasonality was considered
in 28 (24%).
Seven (6%) studies provided a sample size description,
three gave a discussion only with no formal calculation
and four gave a calculation of which one could be repro-
duced. For these four, the sample size was based on de-
tecting an “importance difference” for two studies, while
the remainder determined what effect size and power
was detectable based on data they had. However all four
Fig. 1 PRISMA diagram
Table 1 ITS study characteristics described in the scientific
abstract
N = 116
Method of analysis given 66 (57)
Number of pre-intervention points stated 34 (29)
Number of post-intervention points stated 33 (28)
Main results reported 85 (73)
Values are n (%)
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based the sample size on comparing differences in pro-
portions pre- and post-intervention.
The unit of analysis was the same as the unit of inter-
vention in 74 (64%) studies and a description of how
missing data was handled was reported in 5% of studies.
A transition period, a period which allows the interven-
tion to take affect was considered in 17% of studies. Sen-
sitivity analysis was carried out in 20 (17%) of studies.
Of these, 16 studies did another form of analysis (e.g. ad-
justed for autocorrelation, seasonality, and covariates),
and two considered a transition period.
Data were presented graphically in 109 (94%) of stud-
ies. Three (3%) studies reported outliers in their data but
only one reanalysed the data with the data point re-
moved. Results of the analysis were reported by 115
(99%) with both relative and absolute figures presented
(Table 4). Change in slope (84%) and change in level
(70%) were the most common intervention effects re-
ported with 33 (28%) reporting both. Of the studies that
reported a change in level, 75 (93%) reported an imme-
diate change while 17 (21%) reported other change in
levels, for example, 12 months after the intervention.
Only 8% reported confidence intervals (CIs) or standard
errors (SEs) along with the relative slope effects, 80% for
an immediate change in level effect and 65% for other
change in level effects.
Table 5 describes the characteristics of the discussion
section of the studies. All studies gave an overall inter-
pretation of results, 113 (97%) studies summarised key
Table 2 Study characteristics of included ITS
N = 116
Study definition provided in at least title, abstract or main
paper
74 (64)
Title, abstract, and main paper 9 (12)
Abstract and main paper 16 (22)
Title and main paper 17 (23)
Title and abstract 1 (1)
Title 5 (7)
Abstract 7 (9)
Main paper 19 (26)
Country of study
USA 39 (34)
UK 18 (16)
Asia 18 (16)
Europe 14 (12)
Canada 11 (9)
Australia 7 (6)
Africa 6 (5)
Middle East 2 (2)
Panama 1 (1)
Type of intervention
Programs (e.g. multifaceted) 41 (35)
Policy (e.g. regulatory) 32 (28)
Health systems 25 (22)
Guidelines 19 (16)
Financial 19 (16)
Behavioural 15 (13)
Sales and dispensing 1 (1)
Level of intervention
Hospital 73 (63)
Hospital department 22 (19)
Individual 17 (15)
GP practices 3 (3)
Pharmacy 1 (1)
Participants
Health professional 92 (79)
Disease 30 (26)
Occupational 3 (3)
Population 1 (1)
Data source
Hospital data 64 (55)
Health records 27 (23)
National data 26 (22)
Insurance data 11 (9)
Other 3 (3)
Table 2 Study characteristics of included ITS (Continued)
N = 116
Type of outcome
Continuous 66 (57)
Rate 38 (33)
Binary 11 (9)
Count 1 (1)
Frequency
Monthly 74 (64)
Quarterly 23 (20)
Yearly 14 (12)
Weekly 2 (2)
Othera 3 (3)
Number of data points - median (25th,75th centile)
Pre-intervention 18 (12–32)
Post-intervention 19 (12–34)
Ratio of pre/ post-intervention data points 1 (1–2)
Transition period (n = 20) 3 (1–9)
Other data points that were accounted for (n = 3) 2 (2–8)
Values are n (%) unless otherwise stated. a 90 day periods; five times over two
weeks before and after; daily
Abbreviations: US United States, UK United Kingdom
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results and one study discussed the impact of outliers in
their data. Forty five (39%) gave a discussion or state-
ment of whether other co-interventions might have
taken place in the study. Weakness and limitations were
discussed in 98 (84%) of studies, and 39 (34%) indicated
strengths.
Discussion
To our knowledge this methodological study is the first
to show inconsistencies and gaps in the reporting of de-
sign features and results of ITS design across a variety of
healthcare studies and the first to describe the different
ways of reporting effect estimates (e.g. relative slope and
level effects and absolute change in slope and level).
Reporting effect estimates is vital to interpret studies,
but due to the variety of possible estimates that could be
reported, this can cause challenges across multiple stud-
ies. For example, a change in level corresponds to the
difference in the time point of interest to the predicted
pre-intervention trend where a change in slope is the
difference between the post- and pre-intervention slopes
[5]. The different effect estimates cannot be combined
together. Therefore, although most individual studies in
this study reported an effect size, the many different
Table 3 Methodology characteristics in included ITS
N = 116
Description of the analysis 115 (99)
Segmented regression 90 (78)
ARIMA model 15 (13)
Generalised estimating equations 7 (6)
Change-point analysis 2 (2)
Mixed model 1 (1)
Autocorrelation was considered 63/115 (55)
Method used to test for autocorrelationa N = 63
Durbin Watson 22 (35)
Autocorrelation function 13 (21)
Partial autocorrelation function 11 (17)
Ljung-Box 3 (5)
Examination of residuals 2 (3)
Portmanteau tests 2 (3)
Autocorrelation probability 1 (2)
No test performed 23 (37)
Autocorrelation present if a test was performed N = 40
No 12 (30)
Yes 25 (63)
Not stated 3 (8)
Method used to adjust for autocorrelation N = 48
Autoregressive error term 14 (29)
Prais-winsten regression model 8 (17)
Differencing 3 (6)
Newey-west standard errors 2 (4)
Yule-walker regression model 2 (4)
Did not specify 19 (40)
Order of autocorrelation N = 48
1 8 (17)
2 3 (6)
3 2 (4)
4 1 (2)
5 1 (2)
Did not specify 33 (69)
Nonstationary was considered 9/115 (8)
Method used to test for non-stationary N = 9
Dicky-Fuller 5 (56)
ACF and PACF 2 (22)
Significance testing 1 (11)
Not stated 1 (11)
Nonstationary was present if a test was performed N = 8
No 4 (50)
Yes 3 (38)
Not stated 1 (13)
Table 3 Methodology characteristics in included ITS (Continued)
N = 116
Method used to adjust for nonstationary N = 3
Differencing 2 (67)
Within the ARIMA model 1 (33)
Seasonality was considered 28/115 (24)
Method used to test for seasonality N = 28
ACF PACF 5 (18)
Regression diagnostic tests 1 (4)
Dicky-Fuller 1 (4)
Just stated a test was performed 4 (14)
No formal test 17 (61)
Seasonality present if a test was performed N = 7
No 6 (86)
Yes 1 (14)
Method used to adjust for seasonality N = 22
Covariate 7 (32)
Seasonal ARIMA 1 (5)
Differencing 1 (5)
Not stated 13 (59)
Sample size description N=115
No 108 (94)
Yes 7 (6)
Values are n (%). Abbreviations: ARIMA, Autoregressive integrated moving
average; GEE generalized estimating equation; ACF, autocorrelation function;
PACF Partial autocorrelation function
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ways of reporting make meta-analyses difficult. In
addition, none of the included studies based the sample
size justification on the effect size of interest, making in-
terpretation of a meaningful difference difficult. For ex-
ample, the sample size calculation compared differences
in proportions pre- and post-intervention, but the effect
size was a difference in slope [9].
Only 74 (64%) of studies provided a study definition in
at least the title, abstract, or the main paper with defini-
tions varying between them and only 29 studies referring
to ITS. As ITS studies can be included in systematic re-
views a clear and consistent definition is needed. This is
so researchers can identify ITS studies to be included in
their review and be sure no studies are missed because
of the study definition.
This study identified five statistical methods used to
analysis ITS data (Table 5), however there has been no
research comparing ITS methods to determine which
one to use and when. Also, the varying statistical
methods can have implications on what effect estimates
are reported, which can impact on the interpretation of
results and effect the pooling of results for a meta-
analysis.
It was not possible to determine whether the statistical
analysis performed was appropriate in some cases. Our
study found that one study did not provide any descrip-
tion of the analysis and of the 115 that did only 55%
considered autocorrelation, 10% non-stationary and 28%
seasonality. These figures are slightly lower than the pre-
vious reviews of Jandoc et al [7]. (autocorrelation 66%;
non-stationary 15%; seasonality 31%), while Polus et al
[6]. reported autocorrelation and non-stationary in 31%
of studies. For ITS studies these considerations are im-
portant as it can cause the results either to be underesti-
mated or overestimated which could affect the overall
conclusions of studies.
This study had no restrictions on the type of interven-
tion included, language of report and included 116 stud-
ies, therefore the findings are representative of ITS
studies that are published. However there were some
limitations. Only one year was searched, 2015, but there
are no reasons to believe that other years would give a
markedly different perspective. We potentially could
have missed papers due to the inconsistency in the
reporting of the definition of an ITS study as well as not
searching grey literature and other databases but we do
not see these limitations biasing the representativeness
of ITS studies.
Conclusions
Currently reporting is poor. Jandoc et al [7] provided
reporting recommendations of ITS studies, however our
study has identified gaps in reporting which are not in-
cluded. In the statistical methods section of the study, a
Table 4 ITS study effect sizes reported
N = 116
Relative effects
Relative slope 13 (11)
Relative to: N = 13
Baseline trend 8 (62)
Not stated 5 (38)
CI/SE reported 1 (8)
p-value reported 2 (15)
Relative level 16 (14)
Relative to: N = 16
Baseline trend 13 (81)
Last pre-intervention data point 1 (6)
Not stated 2 (13)
CI/SE reported 8 (50)
p-value reported 6 (38)
Absolute effects
Change in slope 97 (84)
CI/SE reported 74/97 (76)
p-value reported 84/97 (87)
Change in level 81 (70)
Immediate 75/81 (93)
CI/SE reported 60/75 (80)
p-value reported 67/75 (89)
Other level effects 17/81 (21)
CI/SE reported 11/17 (65)
p-value reported 8/17 (47)
Other estimates reported
Intercept 40 (34)
Pre-slope trend 74 (64)
Post-slope trend 15 (13)
Values are n (%). Abbreviations: CI Confidence interval, SE Standard error
Table 5 Discussion of findings in ITS studies
N = 116
Key results summarised with reference to objectives
No 2 (2)
Yes 113 (97)
Some 1 (1)
Discussion of bias 65 (56)
Weaknesses/limitations 98 (84)
Strengths 39 (34)
Values are n (%)
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description of a sample size calculation or a justification
should be provided and if present, how missing data was
handled. For reporting of effect sizes, there needs to be
consistency in what should definitely be reported along
with confidence intervals. Also, the study design should
be indicated in the main paper in addition to the title
and abstract. Therefore, there is a need to provide
clearer guidelines for reporting standards through con-
sensus approaches such as a consensus meeting or a
Delphi study. In additional to poor reporting of ITS
studies, this study highlighted that there are numerous
ways of analysing ITS studies. This can make interpret-
ation of results difficult, for example presenting effect
sizes as either relative or absolute. This illustrates the
need to assess methodological strengths and weaknesses
of current ITS analysis methods.
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